"
Team:Wageningen UR/Applications
From 2013.igem.org
Karrenbelt (Talk | contribs) |
Jingjing4028 (Talk | contribs) |
||
| Line 16: | Line 16: | ||
<li class="fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li> | <li class="fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li> | ||
<li class="fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Engineering_morphology">Host engineering</a></li> | <li class="fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Engineering_morphology">Host engineering</a></li> | ||
| - | <li class="currentlast"> | + | <li class="currentlast">Summary</li> |
</ul> | </ul> | ||
</div> | </div> | ||
<div class="pagina-titel"> | <div class="pagina-titel"> | ||
| - | <h1> | + | <h1>Summary</h1> |
<h2>Subtitle</h2> | <h2>Subtitle</h2> | ||
<img src="http://beauvillemedia.nl/igem/dna.png"/> | <img src="http://beauvillemedia.nl/igem/dna.png"/> | ||
| Line 32: | Line 32: | ||
<html> | <html> | ||
<h3>subparagraph title</h3> | <h3>subparagraph title</h3> | ||
| - | <p> | + | <p>Concluding our iGEM project in 2013, we introduced Aspergillu Niger as a potential host into iGEM. With the host engineering, we stepped further to the next level of synthetic biology. In this GRAS organism, we established a modular system of domain shuffling in order to express a variety of secondary metabolites. The lovastatin as a crucial compound in medical industry was further studied and the domains of its key enzyme was assembled and modular. Via the modularity approach, their physiology was modified to some extent to comply the need of industry. Additionally, to target the production of specific compartment, a toolkit including pH sensor, ATP sensor and visible chromoprotein display was created. It accelerated the exploration of more potentiality. </p> |
| + | |||
| + | <p>For the further study, we recommend to make the toolkit more completed and increase the repertoire with new part and devices. And our mix-match assembling method can be better improved to produce more valuable secondary metabolites. | ||
| + | |||
| + | </p> | ||
</div> | </div> | ||
Revision as of 10:48, 1 October 2013
- Safety introduction
- General safety
- Fungi-related safety
- Biosafety Regulation
- Safety Improvement Suggestions
- Safety of the Application
Summary
Subtitle
paragraph title
subparagraph title
Concluding our iGEM project in 2013, we introduced Aspergillu Niger as a potential host into iGEM. With the host engineering, we stepped further to the next level of synthetic biology. In this GRAS organism, we established a modular system of domain shuffling in order to express a variety of secondary metabolites. The lovastatin as a crucial compound in medical industry was further studied and the domains of its key enzyme was assembled and modular. Via the modularity approach, their physiology was modified to some extent to comply the need of industry. Additionally, to target the production of specific compartment, a toolkit including pH sensor, ATP sensor and visible chromoprotein display was created. It accelerated the exploration of more potentiality.
For the further study, we recommend to make the toolkit more completed and increase the repertoire with new part and devices. And our mix-match assembling method can be better improved to produce more valuable secondary metabolites.
